Arcus Capital Partners, LLC Johnson & Johnson Transaction History

Arcus Capital Partners, LLC

$229 Million
Q1 2025

A detailed history of Arcus Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Arcus Capital Partners, LLC holds 2,419 shares of JNJ stock, worth $370,711. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,419

Previous 2,415 0.17%

Holding current value

$370,711

Previous $349,000 14.9%

% of portfolio

0.18%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$142.06 - $167.7 $568 - $670	4 Added 0.17%	2,419 $401,000
Q4 2024 Jan 30, 2025	SELL	$143.34 - $165.86 $573 - $663	-4 Reduced 0.17%	2,415 $349,000
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $110,564 - $127,208	-760 Reduced 23.91%	2,419 $392,000
Q2 2024 Jul 24, 2024	BUY	$144.38 - $157.78 $110,306 - $120,543	764 Added 31.64%	3,179 $464,000
Q2 2023 Jul 18, 2023	SELL	$154.35 - $166.11 $308 - $332	-2 Reduced 0.08%	2,415 $399,000
Q3 2022 Oct 25, 2022	SELL	$161.33 - $179.52 $15,165 - $16,874	-94 Reduced 3.74%	2,417 $395,000
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $336 - $372	2 Added 0.08%	2,511 $446,000
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $14,707 - $16,701	-93 Reduced 3.57%	2,509 $445,000
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $121,313 - $134,601	778 Added 42.65%	2,602 $445,000
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $26,647 - $29,612	-165 Reduced 8.3%	1,824 $295,000
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $90,903 - $97,509	-570 Reduced 22.27%	1,989 $328,000
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $18,674 - $20,798	-122 Reduced 4.55%	2,559 $421,000
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $367,591 - $421,935	2,681 New	2,681 $422,000
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $164,019 - $183,644	-1,292 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$131.15 - $144.24 $57,312 - $63,032	-437 Reduced 25.27%	1,292 $180,000
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $212,390 - $255,615	1,729 New	1,729 $223,000
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $314,501 - $372,423	-2,514 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $101,039 - $110,587	770 Added 44.15%	2,514 $351,000
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $225,795 - $236,102	1,744	1,744 $227,000

Others Institutions Holding JNJ

# of Institutions

4,652

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $401B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcus Capital Partners, LLC with notifications on news.

Account

Arcus Capital Partners, LLC Johnson & Johnson Transaction History